Insights

Innovative Therapeutic Platform HotSpot Therapeutics specializes in discovering allosteric therapies that target regulatory hotspots on proteins, offering highly selective and potent treatments for diseases with limited current options. This unique approach presents opportunities to collaborate with pharmaceutical companies seeking novel modality pipelines.

Strategic Collaborations The company's recent partnership with AbbVie and ongoing collaborations signal a strong interest from major industry players in advanced autoimmune therapy programs, indicating a potential avenue for expansion through licensing, joint ventures, or co-development deals.

Expanding Pipeline HotSpot is actively advancing preclinical data for programs targeting autoimmune and cancer-related pathways, providing sales prospects for platform licensing, research tools, or early-stage compound development services to biotech and pharma partners.

Funding & Growth With substantial funding of 100 million dollars and revenue between 10 and 25 million dollars, the company is positioned for growth, creating opportunities to offer research tools, consulting, or strategic partnerships to accelerate their development pipeline.

Leadership & Industry Presence Recent key hiring in medical and business leadership, along with active participation in major industry congresses, highlights a focus on advancing clinical development and visibility, which can open doors for service providers in clinical research, medical affairs, and scientific communications.

HotSpot Therapeutics, Inc. Tech Stack

HotSpot Therapeutics, Inc. uses 8 technology products and services including WordPress, Open Graph, MySQL, and more. Explore HotSpot Therapeutics, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • MySQL
    Database
  • Google Workspace
    Email
  • JSON-LD
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • GraphPad Prism
    Visualisation Software
  • Apache
    Web Servers

Media & News

HotSpot Therapeutics, Inc.'s Email Address Formats

HotSpot Therapeutics, Inc. uses at least 1 format(s):
HotSpot Therapeutics, Inc. Email FormatsExamplePercentage
FLast@hotspotthera.comJDoe@hotspotthera.com
49%
First.Last@hotspotthera.comJohn.Doe@hotspotthera.com
1%
FLast@hotspotthera.comJDoe@hotspotthera.com
49%
First.Last@hotspotthera.comJohn.Doe@hotspotthera.com
1%

Frequently Asked Questions

What is HotSpot Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact HotSpot Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is HotSpot Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
HotSpot Therapeutics, Inc.'s official website is hotspotthera.com and has social profiles on LinkedInCrunchbase.

What is HotSpot Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
HotSpot Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does HotSpot Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, HotSpot Therapeutics, Inc. has approximately 60 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer: E. J.Chief Medical Officer: A. M. O.Chief Business Officer: P. T.. Explore HotSpot Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does HotSpot Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
HotSpot Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does HotSpot Therapeutics, Inc. use?

Minus sign iconPlus sign icon
HotSpot Therapeutics, Inc.'s tech stack includes WordPressOpen GraphMySQLGoogle WorkspaceJSON-LDjQueryGraphPad PrismApache.

What is HotSpot Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
HotSpot Therapeutics, Inc.'s email format typically follows the pattern of FLast@hotspotthera.com. Find more HotSpot Therapeutics, Inc. email formats with LeadIQ.

How much funding has HotSpot Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, HotSpot Therapeutics, Inc. has raised $100M in funding. The last funding round occurred on Nov 29, 2021 for $100M.

When was HotSpot Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
HotSpot Therapeutics, Inc. was founded in 2017.

HotSpot Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways.  Unlike conventional drug discovery, which focuses on targeting the active sites of proteins, HotSpot has developed a technology platform to uncover nature’s privileged regulatory hotspots – pockets remote from the active site that are critical to protein function. Our team is designing novel therapies directed at regulatory hotspots, allowing us to treat diseases with limited or no known treatment options.  Hotspot medicines are superior to conventional therapeutics given their exquisite selectivity, potent in vivo pharmacology and attractive drug-like properties.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $100M

    HotSpot Therapeutics, Inc. has raised a total of $100M of funding over 4 rounds. Their latest funding round was raised on Nov 29, 2021 in the amount of $100M.

  • $10M$25M

    HotSpot Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $100M

    HotSpot Therapeutics, Inc. has raised a total of $100M of funding over 4 rounds. Their latest funding round was raised on Nov 29, 2021 in the amount of $100M.

  • $10M$25M

    HotSpot Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.